Paul B. Beeson K76 Guide 2026: Eligibility
Updated 6 official sources
Quick Answer: The Paul B. Beeson K76 is open now. NIA posted PAR-27-112 (opens in a new tab) (K76 Clinical Trial Not Allowed) on Sept.
Full answer and how we checked it
1, 2026, and it runs through June 12, 2028. It's best if you're an early-stage clinician-scientist whose research sits clearly inside aging or geriatrics and who can show a leadership path beyond a normal mentored K award. If the project is only loosely tied to older adults, or if the candidate is still building a basic mentored record, compare K08, K23, K99/R00, R01, and foundation aging awards before writing.
Who this is for: Faculty investigators, department chairs, research development offices, and aging-research mentors deciding whether the Beeson K76 is the right route before a team spends proposal time.
Data note: This guide uses NIH K-series guidance, NIA Beeson K76 notices, the PAR-27-112 record on Grants.gov (opens in a new tab) checked on Oct. 10, 2026, and the live Paul B. Beeson program page.
In this guide
Quick Facts
- Agency
- HHS
- Deadline
- Jun 12, 2028
- Status
- Open
Assistance Listing 93.866: all awards
Source: USASpending.gov FY2024These figures cover all National Institutes of Health awards under Assistance Listing 93.866, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.
- Total Awards (FY2024, whole listing)
- 10,364
- Avg Award (whole listing)
- $3,365,037
- Median Award (whole listing)
- $1,781,166
- Total Funding (FY2024, whole listing)
- $3.8B
- YoY Funding Trend
- -0.1%
Data last verified: May 18, 2026
The Beeson K76 is not just another NIH K award. The official NIH K-series pages explain career-development awards broadly, but Beeson searchers usually need a narrower decision: is this candidate already far enough along to look like an emerging leader in aging, yet still early enough to need protected career-development time?
Use this guide with the live Paul B. Beeson Emerging Leaders program page. The program page gives current status, official source links, award data, and public fit signals. This guide explains the choice between Beeson, K08, K23, K99/R00, R01, and other aging-funding routes.
For broader NIH route selection, compare NIH grants complete guide, NIH R01, R21, R03, and K awards comparison, and NIH K99/R00 pathway to independence.
Teams often make the same mistake with this award: they read "career development" and treat Beeson like a safer K08 or K23. It isn't.
3 Fit Tests for the Beeson K76
The first job is deciding whether this K76 route fits, and 3 tests settle most cases. According to PAR-27-112, posted Sept. 1, 2026, candidates must have received competitively awarded research support as a PD/PI at the faculty level, or have otherwise leveraged faculty-level support to build an independent line of research, and must show leadership in the clinical or research domain. Prior NIA Beeson notices framed the program the same way: it's built for scientists prepared to take an active leadership role in aging-linked research or health outcomes.
| Test | Strong Beeson signal | Weak signal |
|---|---|---|
| Aging focus | The research question is clearly about aging, geriatrics, or older-adult outcomes | Aging appears only as a subgroup or future application |
| Candidate stage | Faculty-level research support, lead-author work, and mentor depth are visible | The record is still mostly trainee-level |
| Leadership plan | The plan shows field-building, methods growth, or specialty-level leadership | The plan reads like a standard mentored project |
The first screen is not prestige. It is fit. A strong biomedical project can still be a poor Beeson choice if the aging thread is weak.
Aging Focus
The Beeson page should answer the question a reviewer will ask first: why should NIA treat this as aging research rather than general clinical, translational, or population-health research?
Good fit examples include:
- age-related disease mechanisms
- geriatrics care delivery
- older-adult functional outcomes
- dementia, frailty, multimorbidity, or late-life health systems research
- aging-linked clinical or translational methods
Poor fit examples include:
- a general disease study with older adults included only because they are common patients
- a methods project that could apply to any adult group with no aging-specific rationale
- a clinical trial that does not explain why older-adult biology, care patterns, or outcomes matter
Candidate Stage
Prior Beeson notices asked applicants to describe prior or current competitive research support, lead-author peer-reviewed publications, and leadership in clinical or research settings. That is a higher bar than "promising junior investigator."
If the candidate does not yet have that record, the better route may be a K08, K23, K01, K99/R00, or foundation early-career award. If the candidate already has independent funding and a clear R01 path, Beeson may no longer be the best use of proposal time.
Leadership Plan
The leadership plan should not be a thin mentoring paragraph. It should explain what the candidate will be able to lead after the award that they cannot lead now.
Strong plans often show:
- a new method or field bridge
- a mentor team with aging depth
- a publication and funding path
- clinical or research leadership roles
- training that changes the candidate's future role
Clinical-Trial Route: Do Not Guess
Two prior notices, RFA-AG-24-014 and RFA-AG-24-015, split Beeson into independent-clinical-trial-not-allowed and clinical-trial-required versions. The current notice, PAR-27-112, is Clinical Trial Not Allowed: applicants can't lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but they may propose a research experience in a trial led by a mentor or co-mentor. Grantsights checked the PAR-27-112 record on Grants.gov (opens in a new tab) on Oct. 10, 2026, and we compared it with the two prior RFAs. No clinical-trial-required Beeson notice was posted then.
| Project role | Likely route question |
|---|---|
| Candidate leads an independent trial, feasibility study, or ancillary trial | Not allowed under PAR-27-112; ask NIA whether another route exists |
| Candidate analyzes existing clinical data or observational outcomes | Check NIH's clinical-trial definition; non-trial work fits PAR-27-112 |
| Candidate gains research experience in a trial led by a mentor or co-mentor | Permitted under PAR-27-112 |
| No human-subject intervention | Fits the clinical-trial-not-allowed route |
Don't reuse an old RFA-AG-24-014 application shell without checking PAR-27-112. NIH clinical-trial classification can change what sections, protections, and review points matter.
Beeson vs. K08, K23, K99/R00, and R01
Beeson isn't the right route for every aging investigator. 6 routes are worth comparing before you commit. Applicants often compare Beeson against better-known NIH mechanisms, and the right answer depends on applicant stage and project center of gravity.
| Route | Best fit | Main reason to choose it over Beeson |
|---|---|---|
| Beeson K76 | Early-stage faculty leader in aging research | Aging leadership is the core case |
| K08 | Clinician-scientist with mentored research training needs | Translational or basic clinical-science training is the main gap |
| K23 | Patient-oriented clinician-scientist | Direct patient-oriented research is central |
| K99/R00 | Postdoc moving to independence | Candidate is not yet in a stable faculty route |
| R01 | Independent research project | Candidate and project no longer need career-development framing |
| Foundation aging award | Narrow aging mission, smaller scope, or bridge path | Funder mission fits better than NIH timing |
For the live award record, use the Beeson K76 program page. For broader NIH planning, use NIH grants complete guide.
What NIH Doesn't Tell You
4 gaps matter here. NIH tells you the rules, but it does not rank your route choices, test the candidate's readiness, or tell you whether the proposal is drifting into a weaker mechanism.
First, the official notice cannot tell you whether the candidate's aging rationale is strong enough. Otherwise strong drafts sometimes have good science but mention aging only in the significance section. That is a weak Beeson posture. The aging question should shape aims, measures, cohort logic, mentor selection, and career plan.
Second, the official notice does not compare Beeson against the candidate's actual next-best route. A clinician doing patient-oriented research may be better served by K23. A physician-scientist needing lab training may belong on K08. A postdoc still moving into faculty independence may belong on K99/R00. A faculty member ready for a research-project frame may need R01 instead.
Third, the official notice does not show whether the applicant's leadership evidence is persuasive enough. A committee can see the candidate's publications and prior awards, but the public page does not translate that into a practical stop/go decision for the grant team.
Fourth, the official notice doesn't put Beeson in funding context. According to USAspending.gov (opens in a new tab) data, assistance listing 93.866 had about $3.83B in FY2024 obligations. That figure covers NIA's whole extramural research portfolio, not Beeson, so it says nothing about how many Beeson awards NIA makes or how competitive the K76 is.
The common mistake is treating "eligible" as "worth applying." This trap shows up when a candidate has a strong clinical record but the aging argument depends on one paragraph. That is a red flag. A Beeson proposal that cannot explain why older-adult outcomes drive the whole project will lose points even if the investigator is impressive.
4 Real-World Beeson Scenarios
4 real scenarios show how the decision changes in practice, especially when the same investigator could plausibly choose a K award or an R-series route.
| Scenario | Better first read | Why |
|---|---|---|
| Geriatrician with pilot data, aging mentors, and faculty-level support | Beeson K76 | The leadership and aging case are central |
| Surgeon studying post-operative outcomes with older adults as one subgroup | K08, K23, or R01 | Aging may not be the main scientific frame |
| Postdoc with strong aging publications but no faculty appointment | K99/R00 or foundation route | Beeson usually expects a faculty-stage record |
| Established aging investigator with independent funding | R01 or program project route | Career-development framing may be too late |
Example 1: a geriatrician studying fall-risk interventions after hospital discharge can make a strong Beeson case if the plan connects older-adult outcomes, mentor depth, implementation path, and a leadership role in geriatrics research.
Example 2: a cardiology project with 30% older patients is not automatically a Beeson project. If the biology, measures, and future work are not centered on aging, the team should not force the mechanism.
Example 3: a PhD scientist with a strong aging postdoc record but no faculty appointment may be a better K99/R00 candidate. Beeson can be too advanced if the institutional role and leadership frame are not ready.
Example 4: a faculty investigator with a funded R01 application path may not need Beeson. In that case, the better question is whether the next application should be an R01, R21, P01 component, or foundation aging award.
One investigator at a university in Pennsylvania might study delirium outcomes after surgery, have an aging mentor, and hold pilot data from an older-adult cohort. That can be a Beeson conversation. One investigator at a cancer center in Texas might include older adults in a broad toxicity study without an aging-specific measure, mentor, or future leadership plan. That second case may be a K08, K23, or R01 conversation instead.
One hospital-based geriatrician in North Carolina might have 2 lead-author papers, a small foundation aging award, and a mentor team split across geriatrics, implementation science, and biostatistics. That is the kind of fact pattern where Beeson deserves serious review. A general internist with no aging mentor and no older-adult outcome in the aims shouldn't force the mechanism.
5 Beeson Draft Checks to Run First
5 draft checks can prevent a weak Beeson application from moving too far. The strongest drafts make the aging case visible before the reviewer reaches the career-development plan.
| Draft check | Pass signal | Red flag |
|---|---|---|
| Specific aims | Aging question appears in the aim logic | Older adults appear only in significance |
| Candidate record | Prior support and publications support an emerging-leader claim | Record reads like early mentored training only |
| Mentor plan | Mentors cover aging science, method gap, and career path | Mentor list is famous but loosely tied to the plan |
| Trial status | Human-subject role matches the active notice | Team is still debating clinical-trial classification late |
| Future funding | Next R01 or equivalent path is credible | Future funding plan is generic |
The downside of a forced Beeson application is opportunity cost. If the fit is weak, the team can lose an entire cycle that would have been better spent on K23, K08, K99/R00, R01, or a smaller foundation aging award. Don't let program prestige override route fit.
According to NIH's individual career-development overview, K awards usually support mentored research development with salary support and protected time. The Beeson decision is still local: candidate stage, aging center of gravity, mentor quality, and clinical-trial route.
Application Readiness Checklist
8 readiness items should be confirmed before writing:
- The project has a direct aging or geriatrics rationale.
- The candidate has faculty-level research support or a credible equivalent signal.
- The mentor team includes serious aging or geriatrics expertise.
- The leadership plan explains a future role, not just skills training.
- The active notice matches the project's clinical-trial status.
- The institution can protect the needed effort.
- The candidate can explain why Beeson is better than K08, K23, K99/R00, or R01.
- The team has checked current source links from the program page.
Sources
- NIH Individual Career Development overview: grants.nih.gov (opens in a new tab)
- NIH PAR-27-112, Beeson K76 Clinical Trial Not Allowed (current, posted Sept. 1, 2026): grants.nih.gov (opens in a new tab) and Grants.gov (opens in a new tab)
- NIH RFA-AG-24-014, Beeson K76 independent clinical trial not allowed (expired): grants.nih.gov (opens in a new tab)
- NIH RFA-AG-24-015, Beeson K76 clinical trial required (expired): grants.nih.gov (opens in a new tab)
- Grantsights Beeson K76 program page: Paul B. Beeson Emerging Leaders Career Development Award in Aging
Largest awards active in FY2024
One row per recipient, its largest award | 10,364 Assistance Listing records | Avg: $3.4M
University of California, Los Angeles
CA
Regents of the University of Michigan
MI
Use the visible recipient rows as free source context
This program has no reviewed paid report today.
No reviewed paid report is currently offered for this program. The visible source rows remain free.
Frequently Asked Questions
Who is the Paul B. Beeson K76 for?
NIA's current notice, PAR-27-112, invites early-stage clinician-scientists whose work is centered on aging, geriatrics, or health outcomes for older adults and who can show research support, publications, mentors, and leadership promise.
Is the Beeson K76 a normal mentored K award?
No. It is a career-development award, but it isn't a standard K08 or K23. Unlike other mentored K awards, candidates must already have competitively awarded faculty-level PD/PI support or leveraged faculty-level support. Beeson targets emerging leaders in aging research rather than early applicants who only need basic mentored support.
Does the Beeson K76 allow clinical trials?
The current notice, PAR-27-112 (posted Sept. 1, 2026), is Clinical Trial Not Allowed. You can't lead an independent clinical trial, a feasibility study, or an ancillary trial, but you can propose a research experience in a trial led by a mentor or co-mentor. Prior cycles also had a clinical-trial-required version; none was posted on Grants.gov as of Oct. 10, 2026.
What should make an applicant pause before writing?
Pause if the aging link is thin, the candidate lacks faculty-level research support, or the plan reads like a standard mentored K rather than a leadership-development path.
What should applicants compare against Beeson?
Compare K08, K23, K99/R00, R01, institute-specific K routes, and foundation aging awards before choosing Beeson.
Last updated October 10, 2026. Corrected October 10, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
21st Century Community Learning Center Grants: 2026 Status
States split $1.31 billion in 21st CCLC money for 2026-27, but the 2027 budget asks for $0. See open state competitions, subgrant sizes and who wins.
Adoption Grants 2026: Charities, Tax Credit, Foster Care
Adoption grants run $1,000 to $30,000 and go to your agency. See 6 charities, deadlines, the 2026 adoption tax credit of $17,670 and foster care help.
ALL Kids Alabama 2026: Income Limits, Costs, How to Apply
ALL Kids income limits for 2026: up to $7,218 a month for a family of 3, yearly premiums of $52 or $104 per child, copays and how to apply in Alabama.